Cancer Epidemiology

Cancer epidemiology studies the occurrence, distribution, and determinants of malignant neoplasms across populations. Cancer is collectively one of the leading causes of death worldwide, and its epidemiology spans a heterogeneous group of diseases with diverse causes, from tobacco and infections to diet, environment, and inherited susceptibility.

Definition

The branch of epidemiology concerned with the frequency, distribution, causes, and outcomes of malignant neoplasms in populations, treating cancer as a family of related diseases of uncontrolled cell growth.

Scope

The entry covers how cancer incidence, mortality, and survival are measured through registries; the principal modifiable and non-modifiable risk factors; geographic and temporal patterns; and the concept of avoidable cancers. It is a reference topic on disease epidemiology, not clinical or screening guidance for individuals.

Core questions

• How is cancer burden measured, and which cancers contribute most to incidence and mortality?
• What proportion of cancer is attributable to modifiable exposures?
• How do cancer patterns differ across regions and over time?

Key concepts

• Malignant neoplasm
• Cancer registries and incidence
• Age-standardised incidence and mortality
• Survival and stage at diagnosis
• Attributable / avoidable fraction
• Carcinogens (tobacco, infections, radiation, diet)
• Multistage carcinogenesis

Mechanisms

Cancers arise through the accumulation of genetic and epigenetic alterations that confer the capabilities of sustained proliferation, evasion of growth suppression and cell death, and invasion - a multistage process influenced by carcinogenic exposures (Hanahan & Weinberg, 2011). Epidemiologically, a large share of cancer is attributable to identifiable exposures - tobacco, certain infections, alcohol, obesity, ionising and ultraviolet radiation, and specific occupational and dietary factors - which is the basis for the concept of avoidable cancer (Doll & Peto, 1981).

Clinical relevance

Cancer epidemiology underpins prevention (for example tobacco control and vaccination against oncogenic infections), screening-programme design, and the planning of oncology services. This entry summarises how that population evidence is generated and is not a source of individual screening or treatment recommendations.

Epidemiology

Global cancer registries estimate on the order of twenty million new cancer cases and roughly ten million cancer deaths per year, with lung, breast, colorectal, and prostate cancers among the most common, though the leading types vary by sex and region (Bray et al., 2024). Cancer is a leading contributor to disability-adjusted life years, and incidence is projected to rise substantially with population growth and ageing (Vos et al., 2020; Bray et al., 2024).

Evidence & guidelines

Descriptive estimates rest on population-based cancer registries collated internationally, most prominently the GLOBOCAN database maintained by the International Agency for Research on Cancer (Bray et al., 2024). The framework of attributable, avoidable cancer derives from foundational work by Doll and Peto (1981), and mechanistic understanding from cancer-biology synthesis (Hanahan & Weinberg, 2011).

History

Modern cancer epidemiology was shaped by mid-twentieth-century studies linking specific exposures to specific cancers - most decisively tobacco and lung cancer. Doll and Peto's 1981 estimate of avoidable cancer causes provided an influential quantitative framework, and the development of population-based registries enabled systematic international comparison of incidence, mortality, and survival, now coordinated through programmes such as GLOBOCAN.

Debates

How much cancer is preventable?

Estimates of the avoidable fraction of cancer vary with how exposures are attributed and which populations are studied; the original Doll and Peto framework remains a reference point, but the precise share attributable to diet, environment, and lifestyle continues to be debated.

Key figures

• Richard Doll
• Richard Peto
• Freddie Bray

Seminal works

• doll-peto-1981
• bray-2024
• hanahan-weinberg-2011

Frequently asked questions

Is cancer a single disease for epidemiologic purposes?

No. Cancer is a family of many distinct diseases with different cell origins, causes, and prognoses, which is why epidemiology reports incidence, mortality, and survival separately by cancer type and site.

How much cancer is considered preventable?

A substantial fraction of cancer is attributable to modifiable exposures such as tobacco, infections, alcohol, obesity, and radiation, but exact estimates of the avoidable share vary by method and population.